GU Cancers 2021 | Updates in radiotherapy for prostate cancer

Robert Jones, MD, PhD, University of Glasgow & Beatson West of Scotland Cancer Centre, Glasgow, UK, shares an overview of the latest developments in radiotherapy for prostate cancer. Prof. Jones highlights the SAKK 09/10 randomized Phase III study (NCT01272050) investigating dose intensification in the salvage therapy setting, and a study investigating the potential of using genomic prognostic scores to reduce the use of androgen deprivation therapy for patients with intermediate- and poor-risk organ-confined disease. This interview took place during the 2021 Genitourinary Cancers Symposium.